For longer-term research, intermittent dosing schedules may be more practical, with adjustments to the dose amount per administration to achieve the desired cumulative exposure
248,251,252 This mechanism is particularly evident in the use of GLP-1-based drugs, such as GLP-1RAs, in the treatment of T2DM
BPC-157's angiogenic effects directly address this limitation while TB-500 enhances cellular migration to the injury site
150,152,153 Activation of the GLP-1R can enhance insulin secretion, reduce glucagon secretion, delay gastric emptying, 154 and suppress appetite
Can the component ratio be adjusted
Nutrients (2017) 9(4):339